Other Clinical Trial - Abdominal MR Imaging at 3.0T: NCT01007357

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Terminated

This project will facilitate the optimization of body MR imaging at 3 Tesla.

This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.

Recruitment information / eligibility
Status	Terminated
Enrollment	25
Est. completion date	June 30, 2015
Est. primary completion date	June 30, 2015
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	All
Age group	19 Years to 65 Years
Eligibility	Inclusion Criteria: - Subjects between ages of 19 and 65 - Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history - Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas) Exclusion Criteria: - Inability to provide informed consent - A medical or contraindications that will prevent subjects from having a MRI - Subjects with severe renal dysfunction or patients on dialysis

Device:
• Body MR imaging
Body MR imaging will be performed to optimize sequences

Locations
Country	Name	City	State
United States	University of Nebraska Medical Center	Omaha	Nebraska
United States	University of Nebraska Medical Center	Omaha	Nebraska

Sponsors *(2)*
Lead Sponsor	Collaborator
University of Nebraska	Philips Medical Systems

United States,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Optimizing body MR imaging sequences	Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.	2 years